Invention relates to the novel compound of formula I and pharmaceutically acceptable salts thereof and use of the said novel compound for the treatment of asthma. The invention involves design, synthesis and biological evaluation of a novel terpenoid based compound and pharmaceutical acceptable salts thereof which possess multiple therapeutic effects like bronchodilatory, anti- allergic and anti-tussive effects.

For more details about technology: Click here

Invention relates to Preparation Process of racemic 6, 6-dimethyl-3-azabicyclo-[3.1.0]-hexane, a key raw material for the preparation of key intermediate (1R, 2S, 5S) – methyl 6,6-dimethyl -3-azabicyclo [3.1.0] hexane-2 carboxylic acid for the class of inhibitors of Protease such as Boceprevir. The process is efficient and economic as in this preparation process lithium aluminium hydride is not used.

For more details about technology: Click here

Technology relates to a Nutritional Supplements from Green Leafy Vegetables to source all nutritional requirements through normal daily food intake. The products have key ingredients such as beta carotene, xanthophylls, chlorophylls, alpha tocopherol among others from green vegetables and the products are used for relief from stress, acidity, nausea, for weight management and also have health benefits for patients suffering from trauma and other health related issues.
For more details about technology: Click here

Invention relates to a Mouth Exercising Device for Oral Submucuos Fibrosis caused due to betel nut chewing in the form of gutkha, and other tobacco products. The technology is patent pending, prototype of the device as a proof of concept was developed and clinical trials are in progress. The report of the clinical trial is accepted for presentation at meeting of International ”Association for Dental Research” USA in March 2013.

For more details about technology: Click here

Technology relates to a polymer for detection, removal and recovery of toxic components such as volatile organic compounds (VOCs), polycyclic aromatic hydrocarbons (PAHs) and other aromatic pollutants. The Polymer comprises a plurality of tetra phenyl monomer units and its preparation process is also disclosed.

Technology relates to an antibody against phosphorylated Ser-125-NPM1, its production method and use of highly specific antibodies against phosphorylated NPM1. NPM1 is identified as a novel substrate for Aurora kinases A and B, both acting on same site, Ser125 on NPM1 for phosphorylation during the onset of mitosis. Technology also discloses a method and kit used for production and usage of polyclonal antibodies specifically targeting Ser125 phosphorylated NPM1 along with pharmaceutically acceptable carrier could be used in diagnosis of tumor.

For more details about technology: Click here